genOway Shanghai - Legal letter - Product name change

Intellectual property

Event
-
June 27, 2025

In an effort to align our global catalog, our product naming strategy will now be consistent across both our Chinese and French teams' communication and documentation.

Access legal letter here

genOway Shanghai - Legal letter - Product name change

Get in touch

Let us know how we can help

Other news & events

Antibody Engineering & Therapeutics Europe 2026, Basel, Switzerland, May 27-29
Conference
Event
-
May 2026
Read on
BIOLIGN Conference Guangzhou 2026
Conference
Event
-
May 2026
Read on
PEGS Boston, May 11-15, 2026
Conference
genOway presentation
Event
-
May 2026
Read on
Lunch & Learn, May 7th: Accelerating Drug Development Through Predictive and Translatable In Vivo Models
genOway presentation
Event
-
May 2026
Read on
genOway Shanghai at Bionnava China 2026
Conference
Event
-
Apr 2026
Read on
Scientific excellence

From model design to experimental results
Featured in 600+ scientific articles

Collaborative approach

Collaboration with 17 Top Pharmas,
170+ Biotechs and 380+ Academic Institutions

Robust validation data on catalog models

Generated with biopharma partners and in-house

Innovative technologies

and guaranteed freedom to operate

Easy access to models

Models with certified health status from professional breeders in US and Europe